BioSpace News Archive

Baxter International Inc., a leader in patient monitoring, physical assessment and vision screening products, announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.

Matica Biotechnology, Inc. announced the appointment of four experienced leaders in biotechnology and the life sciences to its board of advisors: Charlene Banard, Gerard Fleury, Evan Greger, and Carson Sublett.

From pharmaceuticals to household and personal care products to the fashion and electronics industries, the adoption of green and sustainable chemistry practices across an array of sectors and supply chains can help accelerate the pace towards a more sustainable and healthier world.

Kyowa Kirin, Inc. presented two posters at the American Society for Bone and Mineral Research (ASBMR) 2023 annual meeting in Vancouver, BC, Canada, demonstrating the significant burden and progressive, accumulative nature of X-linked hypophosphatemia (XLH), a rare genetic metabolic bone disease.

joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, launched its new iLESSYS® Biportal Interlaminar Endoscopic Surgical System for the treatment of spinal disorders at the EUROSPINE 2023 Annual Meeting in Frankfurt and at the SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas, marking its global debut.

Abivax SA announced the start of its roadshow in connection with its intention to issue, subject to market and other conditions, 18,675,500 ordinary shares of the Company in an initial public offering of American Depositary Shares, each representing one ordinary share, in the United States and a concurrent offering of ordinary shares in certain jurisdictions outside of the United States.

Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company’s online presentation from the Lytham Partners Fall 2023 Investor Conference taking place on Tuesday October 17, 2023.

Notable Labs, Inc., a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, announced the completion of its merger transaction with VBL Therapeutics and associated financing.

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, announced that it has conducted the first implantations of its novel BowTie SI Fusion System.

PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2023 after market close on Wednesday, November 1, 2023.